Literature DB >> 22514012

Probing riboswitch-ligand interactions using thiamine pyrophosphate analogues.

Liuhong Chen1, Elena Cressina, Neil Dixon, Karl Erixon, Kwasi Agyei-Owusu, Jason Micklefield, Alison G Smith, Chris Abell, Finian J Leeper.   

Abstract

The Escherichia coli thiM riboswitch forms specific contacts with its natural ligand, thiamine pyrophosphate (TPP or thiamine diphosphate), allowing it to generate not only nanomolar binding affinity, but also a high degree of discrimination against similar small molecules. A range of synthetic TPP analogues have been used to probe each of the riboswitch-ligand interactions. The results show that the pyrimidine-sensing helix of thiM is exquisitely tuned to select for TPP by recognising the H-bonding donor and acceptors around its aminopyrimidine ring and also by forming π-stacking interactions that may be sensitive to the electronics of the ring. The central thiazolium ring of TPP appears to be more important for ligand recognition than previously thought. It may contribute to binding via long-range electrostatic interactions and/or by exerting an electron withdrawing effect on the pyrimidine ring, allowing its presence to be sensed indirectly and thereby allowing discrimination between thiamine (and its phosphate esters) and other aminopyrimidines found in vivo. The pyrophosphate moiety is essential for submicromolar binding affinity, but unexpectedly, it does not appear to be strictly necessary for modulation of gene expression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22514012     DOI: 10.1039/c2ob07116a

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  9 in total

1.  Analysis of Chlamydomonas thiamin metabolism in vivo reveals riboswitch plasticity.

Authors:  Michael Moulin; Ginnie T D T Nguyen; Mark A Scaife; Alison G Smith; Teresa B Fitzpatrick
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

2.  SHAPE-enabled fragment-based ligand discovery for RNA.

Authors:  Meredith J Zeller; Oleg Favorov; Kelin Li; Ashok Nuthanakanti; Dina Hussein; Auréliane Michaud; Daniel A Lafontaine; Steven Busan; Alexander Serganov; Jeffrey Aubé; Kevin M Weeks
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-13       Impact factor: 12.779

3.  In silico investigation of riboswitches in fungi: structural and dynamical insights into TPP riboswitches in Aspergillus oryzae.

Authors:  Valdemir Vargas-Junior; Deborah Antunes; Ana Carolina Guimarães; Ernesto Caffarena
Journal:  RNA Biol       Date:  2021-12-31       Impact factor: 4.652

4.  Subsite Ligand Recognition and Cooperativity in the TPP Riboswitch: Implications for Fragment-Linking in RNA Ligand Discovery.

Authors:  Meredith J Zeller; Ashok Nuthanakanti; Kelin Li; Jeffrey Aubé; Alexander Serganov; Kevin M Weeks
Journal:  ACS Chem Biol       Date:  2022-01-21       Impact factor: 5.100

5.  Systematic analysis of the interactions driving small molecule-RNA recognition.

Authors:  G Padroni; N N Patwardhan; M Schapira; A E Hargrove
Journal:  RSC Med Chem       Date:  2020-06-04

6.  Novel TPP-riboswitch activators bypass metabolic enzyme dependency.

Authors:  Christina E Lünse; Fraser J Scott; Colin J Suckling; Günter Mayer
Journal:  Front Chem       Date:  2014-07-28       Impact factor: 5.221

Review 7.  Thiamine and selected thiamine antivitamins - biological activity and methods of synthesis.

Authors:  Adam Tylicki; Zenon Łotowski; Magdalena Siemieniuk; Artur Ratkiewicz
Journal:  Biosci Rep       Date:  2018-01-10       Impact factor: 3.840

Review 8.  Riboswitches as Drug Targets for Antibiotics.

Authors:  Vipul Panchal; Ruth Brenk
Journal:  Antibiotics (Basel)       Date:  2021-01-05

9.  Development of Novel Riboswitches for Synthetic Biology in the Green Alga Chlamydomonas.

Authors:  Payam Mehrshahi; Ginnie Trinh D T Nguyen; Aleix Gorchs Rovira; Andrew Sayer; Marcel Llavero-Pasquina; Michelle Lim Huei Sin; Elliot J Medcalf; Gonzalo I Mendoza-Ochoa; Mark A Scaife; Alison G Smith
Journal:  ACS Synth Biol       Date:  2020-06-04       Impact factor: 5.249

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.